Items where Author is "Pereira, M"

Up a level
Export as [feed] Atom [feed] RSS
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 5.


Mabilleau, G and Pereira, M and Chenu, C (2018) Novel skeletal effects of glucagon-like peptide-1 (GLP-1) receptor agonists. JOURNAL OF ENDOCRINOLOGY, 236. R29-R42.

Pereira, M and Gohin, S and Roux, J-P and Fisher, A and Cleasby, M E and Mabilleau, G and Chenu, C (2017) Exenatide Improves Bone Quality in a Murine Model of Genetically Inherited Type 2 Diabetes Mellitus. Frontiers in Endocrinology, 8 (327).

Pereira, M and Gohin, S and Lund, N and Hvid, A and Smitham, P J and Oddy, M J and Reichert, I and Farley, D and Roux, J P and Cleasby, M E and Chenu, C (2017) Sclerostin does not play a major role in the pathogenesis of skeletal complications in type 2 diabetes mellitus. OSTEOPOROSIS INTERNATIONAL, 28 (1). pp. 309-320.

Pereira, M and Jeyabalan, J and Jorgensen, C S and Hopkinson, M and Al-Jazzar, A and Roux, J P and Chavassieux, P and Orriss, I R and Cleasby, M E and Chenu, C (2015) Chronic administration of Glucagon-like peptide-1 receptor agonists improves trabecular bone mass and architecture in ovariectomised mice. BONE, 81. pp. 459-67.

Lim, SV and Marenzana, M and Hopkinson, M and List, E and Kopchick, J and Pereira, M and Javaheri, B and Roux, J and Chavassieux, P and Korbonits, M and Chenu, C (2015) Excessive growth hormone expression in male GH transgenic mice adversely alters bone architecture and mechanical strength. Endocrinology, 156 (4). pp. 1362-1371.

This list was generated on Sun May 9 07:37:18 2021 BST.